Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7 CAD | +0.43% | -0.28% | +71.57% |
May. 10 | Transcript : Vitalhub Corp., Q1 2024 Earnings Call, May 10, 2024 | |
May. 10 | Vitalhub Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 45.16 times its estimated earnings per share for the ongoing year.
- With an enterprise value anticipated at 4.33 times the sales for the current fiscal year, the company turns out to be overvalued.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+71.57% | 260M | - | ||
+5.91% | 32.95B | C | ||
+20.73% | 8.01B | C- | ||
+34.25% | 4.38B | B- | ||
-29.52% | 2.67B | C- | ||
-13.29% | 1.5B | B | ||
-28.02% | 1.27B | - | C+ | |
-30.53% | 1.2B | - | ||
+11.35% | 996M | C | ||
-38.17% | 864M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- VHI Stock
- Ratings Vitalhub Corp.